| Neuralink, Elon Musk's brain-computer interface (BCI) company, has received FDA approval to launch its "first-in-human clinical study." The neurotech startup is developing the Link brain implant, which could
allow patients with severe paralysis and other neurological conditions
to control external devices and communicate using their thoughts. - For
example, patients with degenerative diseases like ALS could regain
communication abilities through mind-controlled cursor movements and
typing.
- The effort requires invasive brain surgery to implant
the Link, a BCI device connected to thin threads that detect neural
signals.
- Neuralink is also working on an ocular implant to restore human vision and implants for the spinal cord that could restore full-body movement in people with a severed spinal cord.
- While Neuralink is not yet recruiting patients for the clinical trial, the FDA approval raises the question of who would agree to participate.
- Following accusations that it mistreated animal test subjects, Neuralink is under investigation for violating the Animal Welfare Act. It has also been accused of unsafely transporting contaminated devices.
- Musk has said he intends to get an implant himself.
|
